ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息（分红）
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Drugs Made In America Acquisition Corp
10.29
-0.0100
-0.10%
成交量：
7,538.00
成交额：
7.76万
市值：
3.45亿
市盈率：
-183.86
高：
10.29
开：
10.29
低：
10.29
收：
10.30
52周最高：
10.34
52周最低：
9.95
股本：
3,351.71万
流通股本：
2,340.59万
量比：
1.01
换手率：
0.03%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.0560
每股收益(LYR):
-0.0326
净资产收益率：
--
总资产收益率：
--
市净率：
1.53
市盈率(LYR):
-315.18
数据加载中...
总览
公司
新闻
公告
2025/08/15
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/20
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/03/31
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/25
重要事件披露
Form 8-K - Current report
2025/02/25
重要事件披露
Form 8-K - Current report
2025/02/04
重要事件披露
Form 8-K - Current report
2025/01/30
重要事件披露
Form 8-K - Current report
2025/01/23
SEC问询函
Form CORRESP - Correspondence
2025/01/23
SEC问询函
Form CORRESP - Correspondence
2025/01/06
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/01/03
SEC问询函
Form CORRESP - Correspondence
2024/12/09
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/11/25
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/11/07
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/27
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/09/07
[修订]招股说明书
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/08/01
招股说明书
Form S-1 - General form for registration of securities under the Securities Act of 1933
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/DMAA/filings"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DMAA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAA\",,,,,undefined,":{"symbol":"DMAA","market":"US","secType":"STK","nameCN":"Drugs Made In America Acquisition Corp","latestPrice":10.29,"timestamp":1761158934433,"preClose":10.3,"halted":0,"volume":7538,"delay":0,"floatShares":23405912,"shares":33517143,"eps":-0.055968,"marketStatus":"交易中","change":-0.01,"latestTime":"10-22 15:55:11 EDT","open":10.29,"high":10.29,"low":10.29,"amount":77568.37939399999,"amplitude":0,"askPrice":10.3,"askSize":3339,"bidPrice":10.29,"bidSize":3147,"shortable":3,"etf":0,"ttmEps":-0.055968,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1761163200000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":10.3,"postHourTrading":{"tag":"盘后","latestPrice":10.3,"preClose":10.3,"latestTime":"18:15 EDT","volume":9,"amount":92.25,"timestamp":1761084900465},"volumeRatio":1.011893},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DMAA\",,,,,undefined,":{"symbol":"DMAA","floatShares":23405912,"roa":"--","roe":"--","lyrEps":-0.032648,"volumeRatio":1.011893,"shares":33517143,"dividePrice":0,"high":10.29,"amplitude":0,"preClose":10.3,"low":10.29,"week52Low":9.95,"pbRate":"1.53","week52High":10.34,"institutionHeld":0,"latestPrice":10.29,"committee":-0.029602,"eps":-0.055968,"divideRate":0,"volume":7538,"delay":0,"ttmEps":-0.055968,"open":10.29,"prevYearClose":9.98,"prevWeekClose":10.3041,"prevMonthClose":10.27,"prevQuarterClose":10.27,"fiveDayClose":10.3,"twentyDayClose":10.31,"sixtyDayClose":10.2658},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DMAA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-14","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-05-20","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747713600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-03-31","symbol":"DMAA","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DMAA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DMAA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DMAA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DMAA","date":"2025-10-21","current":-183.85506,"percent":0.068421,"low":-5272.922078,"twenty":-717.524833,"median":-709.839561,"eighty":-697.410294,"high":-425.235651,"avg":-727.568955,"sd":475.313065,"marketCap":344891401},"quantilePoints":[{"date":"2025-01-10","current":-608.075079,"twenty":-608.075079,"median":-608.075079,"eighty":-608.075079,"marketCap":291714290},{"date":"2025-01-24","current":-5272.922078,"twenty":-1541.044479,"median":-608.075079,"eighty":-608.075079,"marketCap":2529600000},{"date":"2025-01-31","current":-425.873505,"twenty":-1541.044479,"median":-608.075079,"eighty":-425.745934,"marketCap":204306000},{"date":"2025-02-07","current":-426.936594,"twenty":-608.075079,"median":-426.511358,"eighty":-426.043599,"marketCap":204816000},{"date":"2025-02-14","current":-428.637537,"twenty":-608.075079,"median":-427.4894,"eighty":-426.086123,"marketCap":205632000},{"date":"2025-02-21","current":-429.488008,"twenty":-608.075079,"median":-428.127254,"eighty":-426.213694,"marketCap":206040000},{"date":"2025-02-28","current":-695.318062,"twenty":-642.693308,"median":-428.637537,"eighty":-426.426311,"marketCap":333567715},{"date":"2025-03-07","current":-697.410294,"twenty":-694.899616,"median":-429.062772,"eighty":-426.511358,"marketCap":334571430},{"date":"2025-03-14","current":-696.712883,"twenty":-696.294437,"median":-608.075079,"eighty":-426.7665,"marketCap":334236858},{"date":"2025-03-21","current":-698.805113,"twenty":-697.410294,"median":-608.075079,"eighty":-426.936594,"marketCap":335240572},{"date":"2025-03-28","current":-700.199934,"twenty":-697.689258,"median":-694.620652,"eighty":-427.446877,"marketCap":335909715},{"date":"2025-04-04","current":-700.058307,"twenty":-699.084077,"median":-694.969357,"eighty":-427.94015,"marketCap":335841772},{"date":"2025-04-11","current":-700.756969,"twenty":-700.114958,"median":-695.666767,"eighty":-428.144263,"marketCap":336176944},{"date":"2025-04-17","current":-700.756969,"twenty":-700.534155,"median":-696.712883,"eighty":-428.217404,"marketCap":336176944},{"date":"2025-04-25","current":-702.852952,"twenty":-700.756969,"median":-697.061588,"eighty":-428.39005,"marketCap":337182458},{"date":"2025-05-02","current":-704.250274,"twenty":-701.315898,"median":-697.410294,"eighty":-428.637537,"marketCap":337852801},{"date":"2025-05-09","current":-706.346256,"twenty":-702.154292,"median":-697.758998,"eighty":-428.637537,"marketCap":338858315},{"date":"2025-05-16","current":-706.695588,"twenty":-703.691345,"median":-698.805113,"eighty":-428.977725,"marketCap":339025901},{"date":"2025-05-23","current":-707.743579,"twenty":-704.948934,"median":-699.780416,"eighty":-429.743149,"marketCap":339528658},{"date":"2025-05-30","current":-708.09291,"twenty":-705.647596,"median":-700.058307,"eighty":-465.715705,"marketCap":339696244},{"date":"2025-06-06","current":-709.839561,"twenty":-706.346256,"median":-700.199934,"eighty":-608.075079,"marketCap":340534172},{"date":"2025-06-13","current":-710.538223,"twenty":-706.975053,"median":-700.756969,"eighty":-608.075079,"marketCap":340869344},{"date":"2025-06-20","current":-711.935546,"twenty":-707.743579,"median":-700.756969,"eighty":-608.075079,"marketCap":341539687},{"date":"2025-06-27","current":-711.236883,"twenty":-707.743579,"median":-700.756969,"eighty":-608.075079,"marketCap":341204515},{"date":"2025-07-03","current":-711.935546,"twenty":-708.861436,"median":-701.106301,"eighty":-677.311537,"marketCap":341539687},{"date":"2025-07-11","current":-713.332868,"twenty":-709.979293,"median":-701.738587,"eighty":-694.620652,"marketCap":342210030},{"date":"2025-07-18","current":-714.730188,"twenty":-710.95742,"median":-702.154292,"eighty":-694.620652,"marketCap":342880372},{"date":"2025-07-25","current":-716.826172,"twenty":-711.236883,"median":-702.852952,"eighty":-694.620652,"marketCap":343885887},{"date":"2025-08-01","current":-717.524833,"twenty":-711.935546,"median":-704.250274,"eighty":-695.17858,"marketCap":344221058},{"date":"2025-08-08","current":-717.524833,"twenty":-712.005412,"median":-704.948934,"eighty":-695.318062,"marketCap":344221058},{"date":"2025-08-15","current":-718.223495,"twenty":-713.332868,"median":-705.647596,"eighty":-695.597026,"marketCap":344556230},{"date":"2025-08-22","current":-717.524833,"twenty":-714.17126,"median":-706.342764,"eighty":-695.945732,"marketCap":344221058},{"date":"2025-08-29","current":-716.365056,"twenty":-714.86992,"median":-706.346256,"eighty":-696.573401,"marketCap":343664674},{"date":"2025-09-05","current":-716.826172,"twenty":-716.222528,"median":-706.695588,"eighty":-696.712883,"marketCap":343885887},{"date":"2025-09-12","current":-716.12751,"twenty":-716.48802,"median":-707.044919,"eighty":-696.712883,"marketCap":343550715},{"date":"2025-09-19","current":-718.223495,"twenty":-716.826172,"median":-707.743579,"eighty":-697.13133,"marketCap":344556230},{"date":"2025-09-26","current":-718.132667,"twenty":-716.826172,"median":-707.743579,"eighty":-697.410294,"marketCap":344512657},{"date":"2025-10-03","current":-717.524833,"twenty":-716.826172,"median":-708.09291,"eighty":-697.410294,"marketCap":344221058},{"date":"2025-10-10","current":-718.223495,"twenty":-717.52064,"median":-708.966236,"eighty":-697.410294,"marketCap":344556230},{"date":"2025-10-17","current":-720.319477,"twenty":-717.524833,"median":-709.839561,"eighty":-697.410294,"marketCap":345561744},{"date":"2025-10-21","current":-718.922155,"twenty":-717.524833,"median":-709.839561,"eighty":-697.410294,"marketCap":344891401}],"updateTime":1761162911243},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"DMAA\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"19991186","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025076681-DMAA","pdf_url":"","pub_time":1755202629000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMAA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-076681-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea0252999-10q_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0252999-10q_drugs.htm","type":"10-Q","id":"NTFILE9VqQs8ujH3MQWkVR","market":"us","size":492913},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILE6JZrGYDxPPVc5yUT","market":"us","size":12554},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILE3aMe4cD57MDFBNCN","market":"us","size":12567},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILEGqAqZXg3MJzBBX1G","market":"us","size":4957},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025076681/ea025299901ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea025299901ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILEDDBD119ydaXRjGgz","market":"us","size":4971}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-08-15 04:17","pubTimestamp":1755202629,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19673672","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025046061-DMAA","pdf_url":"","pub_time":1747713600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"DMAA","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/0001213900-25-046061-index.htm","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea0242665-10q_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0242665-10q_drugs.htm","type":"10-Q","id":"NTFILE6VGcRZzQufj8nfND","market":"us","size":392808},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILECeQwy4Fg4gRE4tyc","market":"us","size":10509},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILE7SZGwipQUkJSvtsj","market":"us","size":10510},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILE135Rg4XrTnHJjxPS","market":"us","size":4357},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025046061/ea024266501ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea024266501ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILE4Z3WPDuNTJJTkXSY","market":"us","size":4386}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2025-05-20 12:00","pubTimestamp":1747713600,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19326644","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025026240-DMAA","pdf_url":"","pub_time":1743393600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"DMAA","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/0001213900-25-026240-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea0235148-10k_drugs.htm","primary":true,"translateUrl":"","linkName":"ea0235148-10k_drugs.htm","type":"10-K","id":"NTFILEJ45aWmEve9yWSSvX","market":"us","size":512508},{"description":"DESCRIPTION OF THE COMPANY'S SECURITIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex4-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex4-5_drugs.htm","type":"EX-4.5","id":"NTFILE7bhg4KXK1nWhY5NJ","market":"us","size":70479},{"description":"INSIDER TRADING POLICY","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex19_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex19_drugs.htm","type":"EX-19","id":"NTFILEHUQfkS6yTyp7qZJ2","market":"us","size":42475},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex31-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex31-1_drugs.htm","type":"EX-31.1","id":"NTFILE288ZV7gFeJPDgqDM","market":"us","size":9041},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex31-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex31-2_drugs.htm","type":"EX-31.2","id":"NTFILE4fD3wF7f93g4S8kN","market":"us","size":9074},{"description":"CERTIFICATION","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex32-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex32-1_drugs.htm","type":"EX-32.1","id":"NTFILEBzFkjU6zGvMBKWJP","market":"us","size":3385},{"description":"CERTIFICATION","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex32-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex32-2_drugs.htm","type":"EX-32.2","id":"NTFILEHhqjKmbwsrfbSvhF","market":"us","size":3376},{"description":"CLAWBACK POLICY","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025026240/ea023514801ex97-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea023514801ex97-1_drugs.htm","type":"EX-97.1","id":"NTFILE5ZPWfEoRpeSL8eqT","market":"us","size":23287}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2025-03-31 12:00","pubTimestamp":1743393600,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19167493","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025016702-DMAA","pdf_url":"","pub_time":1740442536000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-016702-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED FEBRUARY 18, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/ea023193601ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea023193601ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEHT4KKAZexViN9c2o","market":"us","size":58923},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016702/ea0231936-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0231936-8k_drugs.htm","type":"8-K","id":"NTFILEHqYY8fFSq22REHEj","market":"us","size":20445}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-25 08:15","pubTimestamp":1740442536,"title_zh":"Form 8-K - Current report","summary_en":"Item 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第3.02项：未经登记的股本证券销售；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19167258","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025016602-DMAA","pdf_url":"","pub_time":1740430753000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-25-016602-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE DATED FEBRUARY 20, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/ea023198001ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea023198001ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILE55TDDeFLokDqaKG5","market":"us","size":7834},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025016602/ea0231980-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0231980-8k_drugs.htm","type":"8-K","id":"NTFILE95fk92JMAGcREX11","market":"us","size":18833}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-25 04:59","pubTimestamp":1740430753,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20137982","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025010079-DMAA","pdf_url":"","pub_time":1738645200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/0001213900-25-010079-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BALANCE SHEET DATED JANUARY 29, 2025","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/ea022985301ex99-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea022985301ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILE4htaeCQuRb8r1ZJz","market":"us","size":137733},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025010079/ea0229853-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0229853-8k_drugs.htm","type":"8-K","id":"NTFILEDUAEZUjL2a8iU5dt","market":"us","size":33315}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-02-04 13:00","pubTimestamp":1738645200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19184969","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025008377-DMAA","pdf_url":"","pub_time":1738213200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"DMAA","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/0001213900-25-008377-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"UNDERWRITING AGREEMENT, DATED JANUARY 27, 2025, BY AND BETWEEN THE COMPANY AND C","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex1-1_drugs.htm","primary":true,"translateUrl":"","linkName":"ea022913501ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE7DEwTSwzD79pnfFo","market":"us","size":244779},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea0229135-8k_drugs.htm","primary":false,"translateUrl":"","linkName":"ea0229135-8k_drugs.htm","type":"8-K","id":"NTFILECR9prfXuF4WriPBY","market":"us","size":37390},{"description":"SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex3-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex3-1_drugs.htm","type":"EX-3.1","id":"NTFILE6y5nBqer6m5VjPCK","market":"us","size":341912},{"description":"RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND BETWEEN THE COMPANY AND VSTOCK T","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEHqQwyw5r8dDBqd4N","market":"us","size":68171},{"description":"LETTER AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY, DRUGS MADE IN","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEB7izsf1QakzE59FV","market":"us","size":46260},{"description":"INVESTMENT MANAGEMENT TRUST AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE C","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-2_drugs.htm","type":"EX-10.2","id":"NTFILE5SWxaFfCpRrB7cKr","market":"us","size":104109},{"description":"REGISTRATION RIGHTS AGREEMENT, DATED JANUARY 7, 2025, BY AND AMONG THE COMPANY A","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEByrWWRBFs3zEaVR2","market":"us","size":103717},{"description":"AMENDED AND RESTATED PRIVATE UNITS SUBSCRIPTION AGREEMENT, DATED JANUARY 27, 202","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILEDA84c9fHpiVdduTH","market":"us","size":25588},{"description":"FORM OF INDEMNITY AGREEMENT BY AND BETWEEN THE COMPANY AND EACH OF THE OFFICERS","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILE6yFhnAew6RYaeFiu","market":"us","size":81921},{"description":"ADMINISTRATIVE SERVICES AGREEMENT, DATED AS OF JANUARY 7, 2025, BY AND BETWEEN T","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILEBpzu9uWtjycodYdV","market":"us","size":10843},{"description":"NOTE CONVERSION AGREEMENT, DATED AS OF JANUARY 29, 2025, BY AND BETWEEN THE COMP","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-7_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-7_drugs.htm","type":"EX-10.7","id":"NTFILEGY6RwEcRaqFUmDo2","market":"us","size":19862},{"description":"PROMISSORY NOTE, DATED AS OF JANUARY 29, 2025, ISSUED TO DRUGS MADE IN AMERICA A","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex10-8_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex10-8_drugs.htm","type":"EX-10.8","id":"NTFILEHnoaKrMyHQskVsmP","market":"us","size":26140},{"description":"PRESS RELEASE DATED JANUARY 27, 2025","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex99-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEHE6FFjRfS4z5b9kq","market":"us","size":8449},{"description":"PRESS RELEASE DATED JANUARY 29, 2025","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ea022913501ex99-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea022913501ex99-2_drugs.htm","type":"EX-99.2","id":"NTFILE3JGbm8bRhiMxNaNN","market":"us","size":7942},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ex3-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_001.jpg","type":"GRAPHIC","id":"NTFILE8nS9kL6Z2gvh6x3D","market":"us","size":17938},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025008377/ex3-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex3-1_002.jpg","type":"GRAPHIC","id":"NTFILEsEB1K5xMUjyL7FwT","market":"us","size":7532}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2025-01-30 13:00","pubTimestamp":1738213200,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；第3.02项：未经登记的股本证券销售；第5.03项：公司章程或章程的修订；财政年度的变化；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20138243","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025005828-DMAA","pdf_url":"","pub_time":1737608400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005828/0001213900-25-005828-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005828/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8dodEiJeAWxXnH3y","market":"us","size":7176}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-01-23 13:00","pubTimestamp":1737608400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20138119","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025005825-DMAA","pdf_url":"","pub_time":1737608400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005825/0001213900-25-005825-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025005825/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE8gPfv6MMCdeeWpuu","market":"us","size":10176}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-01-23 13:00","pubTimestamp":1737608400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"19019096","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025001208-DMAA","pdf_url":"","pub_time":1736139600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/0001213900-25-001208-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/ea0209546-10.htm","primary":true,"translateUrl":"","linkName":"ea0209546-10.htm","type":"S-1/A","id":"NTFILE5gaSz7tH2HwxepV8","market":"us","size":141681},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025001208/ea020954610ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954610ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE2XTHxskw6GrTVt8L","market":"us","size":2505}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2025-01-06 13:00","pubTimestamp":1736139600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20139072","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390025000704-DMAA","pdf_url":"","pub_time":1735880400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form CORRESP - Correspondence","symbol":"DMAA","title":"Form CORRESP - Correspondence","titleType":"SEC问询函","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000704/0001213900-25-000704-index.htm","us_notice_code":"Form CORRESP","us_title_en":"Form CORRESP - Correspondence","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390025000704/filename1.htm","primary":true,"translateUrl":"","linkName":"filename1.htm","type":"CORRESP","id":"NTFILE9NPW8oRFC73iLRkp","market":"us","size":9232}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Correspondence","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"SEC问询函","pubTime":"2025-01-03 13:00","pubTimestamp":1735880400,"title_zh":"Form CORRESP - Correspondence","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18922271","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024106894-DMAA","pdf_url":"","pub_time":1733720400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/0001213900-24-106894-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/ea0209546-08.htm","primary":true,"translateUrl":"","linkName":"ea0209546-08.htm","type":"S-1/A","id":"NTFILE75vGQNkNyZDPkjVc","market":"us","size":4566963},{"description":"AMENDED AND RESTATED PROMISSORY NOTE, DATED AS OF DECEMBER 5, 2024, ISSUED TO DR","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024106894/ea020954608ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954608ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILE2sDgmMASBET1KMMr","market":"us","size":24466}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2024-12-09 13:00","pubTimestamp":1733720400,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18872196","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024102238-DMAA","pdf_url":"","pub_time":1732510800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/0001213900-24-102238-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea0209546-07.htm","primary":true,"translateUrl":"","linkName":"ea0209546-07.htm","type":"S-1/A","id":"NTFILEBm3a5cuan3h8VRhA","market":"us","size":4578563},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILEz9nXdd3A6wjv5Ae2","market":"us","size":242042},{"description":"AMENDMENT TO PROMISSORY NOTE, DATED NOVEMBER 21, 2024, ISSUED TO DRUGS MADE IN A","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex10-9_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex10-9_drugs.htm","type":"EX-10.9","id":"NTFILE6cZcvDAUGuhGv1dE","market":"us","size":10461},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024102238/ea020954607ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954607ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE84AZvh46wZthGVis","market":"us","size":2138}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2024-11-25 13:00","pubTimestamp":1732510800,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18805908","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024095138-DMAA","pdf_url":"","pub_time":1730955600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/0001213900-24-095138-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDMENT NO. 3 TO FORM S-1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea0209546-06.htm","primary":true,"translateUrl":"","linkName":"ea0209546-06.htm","type":"S-1/A","id":"NTFILEGdWGRmCavHS5KFhv","market":"us","size":4384963},{"description":"FORM OF SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex3-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex3-3_drugs.htm","type":"EX-3.3","id":"NTFILE52CqPnGysN62kcvR","market":"us","size":267372},{"description":"SPECIMEN UNIT CERTIFICATE","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEF4Pn74v7TBq4iqjj","market":"us","size":19628},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-2_drugs.htm","type":"EX-4.2","id":"NTFILEH3LeBGruKc6CxeFr","market":"us","size":17389},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN VSTOCK TRANSFER, LLC AND THE REGISTRANT","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex4-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex4-4_drugs.htm","type":"EX-4.4","id":"NTFILEBWg2pSm52NCX3wCn","market":"us","size":69956},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex5-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex5-1_drugs.htm","type":"EX-5.1","id":"NTFILEAUKqhsfbrY2rkbpF","market":"us","size":41444},{"description":"OPINION OF LOEB & LOEB LLP","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex5-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex5-2_drugs.htm","type":"EX-5.2","id":"NTFILEJ1TGCHonbWfQ5hxP","market":"us","size":11240},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILExjQmyedNYNiykkcB","market":"us","size":55274},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT AMONG WILMINGTON TRUST NATIONAL AS","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILE7YGvJfRU75YGJBar","market":"us","size":101759},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILECbZRwPK3Rd7dWCDt","market":"us","size":100105},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILE9f8r4nCgkmaCCCgu","market":"us","size":23889},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEGKtqDTzHTA3yMprw","market":"us","size":1490},{"description":"FILING FEE TABLE","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ea020954606ex-fee_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954606ex-fee_drugs.htm","type":"EX-FILING FEES","id":"NTFILEEdG5QXe9qdJTLmAb","market":"us","size":17953},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILE1L9RiS3qixRhApyn","market":"us","size":11039},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILEHbRNkfrQp1tWCNjf","market":"us","size":12611},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024095138/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILE4DdCFJjwRTcBGpwL","market":"us","size":4190}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2024-11-07 13:00","pubTimestamp":1730955600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18655309","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024082386-DMAA","pdf_url":"","pub_time":1727409600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/0001213900-24-082386-index.htm","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea0209546-04.htm","primary":true,"translateUrl":"","linkName":"ea0209546-04.htm","type":"S-1/A","id":"NTFILEbcBNoigA7EHHGszu","market":"us","size":4370093},{"description":"FORM OF UNDERWRITING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex1-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex1-1_drugs.htm","type":"EX-1.1","id":"NTFILE6bDGdMN5j8gLzAvt","market":"us","size":255602},{"description":"FORM OF SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex3-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex3-3_drugs.htm","type":"EX-3.3","id":"NTFILEFUCimmFp1bMVQrxV","market":"us","size":267362},{"description":"SPECIMEN UNIT CERTIFICATE","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-1_drugs.htm","type":"EX-4.1","id":"NTFILEDgy3e4H1JMudeimH","market":"us","size":19918},{"description":"SPECIMEN ORDINARY SHARE CERTIFICATE","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-2_drugs.htm","type":"EX-4.2","id":"NTFILEBiL65WEDucAdYcrx","market":"us","size":17378},{"description":"FORM OF RIGHTS AGREEMENT BETWEEN VSTOCK TRANSFER, LLC AND THE REGISTRANT","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex4-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex4-4_drugs.htm","type":"EX-4.4","id":"NTFILEGASzErrMw1svD4LH","market":"us","size":69275},{"description":"OPINION OF MAPLES AND CALDER (CAYMAN) LLP","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex5-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex5-1_drugs.htm","type":"EX-5.1","id":"NTFILESeJT2GWtcM6yS5FP","market":"us","size":38746},{"description":"OPINION OF LOEB & LOEB LLP","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex5-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex5-2_drugs.htm","type":"EX-5.2","id":"NTFILE9buuXKMWWf8TjA3c","market":"us","size":11258},{"description":"FORM OF LETTER AGREEMENT AMONG THE REGISTRANT, ITS DIRECTORS AND OFFICERS, AND D","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-3_drugs.htm","type":"EX-10.3","id":"NTFILEHLt2V1ZbZRkPm9Pm","market":"us","size":56331},{"description":"FORM OF INVESTMENT MANAGEMENT TRUST AGREEMENT AMONG WILMINGTON TRUST NATIONAL AS","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-4_drugs.htm","type":"EX-10.4","id":"NTFILE3ZTGw4Bq7fTB7erN","market":"us","size":103298},{"description":"FORM OF REGISTRATION RIGHTS AGREEMENT BETWEEN THE REGISTRANT AND CERTAIN SECURIT","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-5_drugs.htm","type":"EX-10.5","id":"NTFILEHZbLkpyEJ9zZ9Rdv","market":"us","size":98804},{"description":"FORM OF PRIVATE UNITS PURCHASE AGREEMENT BETWEEN THE REGISTRANT AND DRUGS MADE I","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-6_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-6_drugs.htm","type":"EX-10.6","id":"NTFILECHhq4hM6j47a3Zfa","market":"us","size":23878},{"description":"FORM OF INDEMNITY AGREEMENT","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-7_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-7_drugs.htm","type":"EX-10.7","id":"NTFILE5MP2XKGhCs5BpPjB","market":"us","size":95570},{"description":"FORM OF ADMINISTRATIVE SERVICES AGREEMENT BY AND BETWEEN THE REGISTRANT AND AN A","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex10-8_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex10-8_drugs.htm","type":"EX-10.8","id":"NTFILEKPutbfsAZCAgF1F4","market":"us","size":14688},{"description":"FORM OF CODE OF CONDUCT","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex14_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex14_drugs.htm","type":"EX-14","id":"NTFILEEHpA6kEueodwtwwH","market":"us","size":48800},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE4jJaH9sfA1BnB4xM","market":"us","size":3959},{"description":"FORM OF AUDIT COMMITTEE CHARTER","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex99-4_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex99-4_drugs.htm","type":"EX-99.4","id":"NTFILEHRM4u9B8h8GGDNdi","market":"us","size":38309},{"description":"FORM OF COMPENSATION COMMITTEE CHARTER","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ea020954604ex99-5_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954604ex99-5_drugs.htm","type":"EX-99.5","id":"NTFILEDLtrLYoQseaUcVJ2","market":"us","size":31713},{"description":"GRAPHIC","seq":19,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-2_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-2_001.jpg","type":"GRAPHIC","id":"NTFILEEjTYtD9kG3im3Acb","market":"us","size":4190},{"description":"GRAPHIC","seq":20,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-1_001.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEHxTfSTkKCk2vAHZp","market":"us","size":11039},{"description":"GRAPHIC","seq":21,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024082386/ex5-1_002.jpg","primary":false,"translateUrl":"","linkName":"ex5-1_002.jpg","type":"GRAPHIC","id":"NTFILE3Xy4HXa7ahw9ZvG1","market":"us","size":12611}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2024-09-27 12:00","pubTimestamp":1727409600,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18591895","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024076546-DMAA","pdf_url":"","pub_time":1725654597000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","symbol":"DMAA","title":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","titleType":"[修订]招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/0001213900-24-076546-index.html","us_notice_code":"Form S-1/A","us_title_en":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/ea0209546-02.htm","primary":true,"translateUrl":"","linkName":"ea0209546-02.htm","type":"S-1/A","id":"NTFILEAH1xB9ooMsoDUf92","market":"us","size":4364625},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024076546/ea020954602ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954602ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILE8NypJrEjxYdqaZT4","market":"us","size":2499}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"[Amend]Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"[修订]招股说明书","pubTime":"2024-09-07 04:29","pubTimestamp":1725654597,"title_zh":"Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"18655310","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390024064074-DMAA","pdf_url":"","pub_time":1722484800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-1 - General form for registration of securities under the Securities Act of 1933","symbol":"DMAA","title":"Form S-1 - General form for registration of securities under the Securities Act of 1933","titleType":"招股说明书","type":"usProspectusesRegistrations","url":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/0001213900-24-064074-index.htm","us_notice_code":"Form S-1","us_title_en":"Form S-1 - General form for registration of securities under the Securities Act of 1933","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"REGISTRATION STATEMENT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea0209546-01.htm","primary":true,"translateUrl":"","linkName":"ea0209546-01.htm","type":"S-1","id":"NTFILEA6w1erH74trA3SbS","market":"us","size":4342212},{"description":"MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex3-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex3-1_drugs.htm","type":"EX-3.1","id":"NTFILEC3BK41cp5D19L3KX","market":"us","size":242396},{"description":"AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex3-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex3-2_drugs.htm","type":"EX-3.2","id":"NTFILE6nyNFQT3NwYYP8RT","market":"us","size":211632},{"description":"PROMISSORY NOTE, DATED JUNE 14, 2024, ISSUED TO DRUGS MADE IN AMERICA ACQUISITIO","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex10-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex10-1_drugs.htm","type":"EX-10.1","id":"NTFILEBPRrQuF6QGAbckwe","market":"us","size":19191},{"description":"SECURITIES SUBSCRIPTION AGREEMENT, DATED JUNE 14, 2024, BETWEEN THE REGISTRANT A","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex10-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex10-2_drugs.htm","type":"EX-10.2","id":"NTFILE3onGt9FpjpPMHXYy","market":"us","size":45339},{"description":"CONSENT OF MALONEBAILEY, LLP","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex23-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex23-1_drugs.htm","type":"EX-23.1","id":"NTFILEAg5THzHSiQDx45KC","market":"us","size":3678},{"description":"CONSENT OF CATHERINE DO","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-1_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-1_drugs.htm","type":"EX-99.1","id":"NTFILEHpe5P9QqmQoNrvGq","market":"us","size":1993},{"description":"CONSENT OF G. SRIDHAR PRASAD","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-2_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-2_drugs.htm","type":"EX-99.2","id":"NTFILEEpXJroHBTNqtiBYT","market":"us","size":2022},{"description":"CONSENT OF MYRON W. SHULGAN","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex99-3_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex99-3_drugs.htm","type":"EX-99.3","id":"NTFILE5MZGrip4qeRSPwd4","market":"us","size":2019},{"description":"FILING FEE TABLE","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2028614/000121390024064074/ea020954601ex-fee_drugs.htm","primary":false,"translateUrl":"","linkName":"ea020954601ex-fee_drugs.htm","type":"EX-FILING FEES","id":"NTFILEBpkQ6t631a4vpB7f","market":"us","size":17530}],"type_name":"招股注册","type_name_en":"Recruitment Registration","titleTypeEn":"Public Prospectus","us_type":"usProspectusesRegistrations","us_type_zh":"招股注册","earn_infos":[],"event_type":"important_notice","event_name":"招股说明书","pubTime":"2024-08-01 12:00","pubTimestamp":1722484800,"title_zh":"Form S-1 - General form for registration of securities under the Securities Act of 1933","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":17,"code":"91000000","status":"200"}]}}